Prevalence of antinucleosome antibodies by enzyme-linked immunosorbent assays in patients with systemic lupus erythematosus and other autoimmune systemic diseases

Annals of the New York Academy of Sciences

Volumn 1109, Issue , 2007, Pages 275-286

  Půtová, Ivana ^a   Dostal, C ^a   Becvar, R ^a  

^a INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

Author keywords

Anti ds DNA antibodies; Antihistone antibodies; Antinuclear antibodies; Antinucleosome antibodies; Sj gren syndrome (SS); Systemic lupus erythematosus (SLE); Systemic sclerosis (SSc)

Indexed keywords

DOUBLE STRANDED DNA ANTIBODY; HISTONE ANTIBODY; NUCLEOSOME ANTIBODY; ANTINUCLEAR ANTIBODY;

ADULT; ANTIBODY DETECTION; AUTOIMMUNE DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; ARTICLE; BLOOD; HEALTH; IMMUNOLOGY; METHODOLOGY; NUCLEOSOME;

ADULT; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; NUCLEOSOMES;

EID: 34848907159     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1398.033     Document Type: Conference Paper

References (30)

1. VENCOVSKÝ, J. 1998. Autoimunitní systémová onemocňní, 1. vydání. Triton Praha. 50-70.
2. DOSTÁL, C. et al. 1997. Systémový lupus erythematodes. Medprint. Cheb. 9-56.
3. SINICO, R.A. et al. 2002. The use of laboratory tests in diagnosis and monitoring of systemic lupus erythematosus. J. Nephrol. 15: S20-S27.
4. TAN, E.M. 1994. Meaning of autoantibodies in lupus-like syndromes. Lupus 3: 483-485.
5. VON MUHLEN, Ch.A. & E.M. TAN. 1995. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin. Arthritis Rheum. 4: 323-358.
6. DOSTÁL, C. et al., 2003. Systémový lupus erythematodes. In Klinická Revmatologie. K. PAVELKA et al., Eds.: 235-260. Galén. Praha.
7. ISENBERG, D.A. et al. 1994. The origin, sequence structure, and consequences of developing anti-ds DNA antibodies. A human perspective. Arthritis Rheum. 37: 169-180.
8. KRISHNA, P. et al. 1993. Interactions of anti-DNA antibodies with Z-DNA. Clin. Exp. Immunol. 92: 51-57.
9. KOFFER, D. et al. 1974. Polynucleotide immune complexes in serum and glomeruli of patients with systemic lupus erythematosus. Am. J. Pathol. 74: 109.
10. SIROTA, P. et al. 1993. Autoantibodies to DNA in multicase families with schizophrenia. Biol. Psychiatry 33: 450-455.
11. SMEENK, R. et al. 1990. Autoantibodies to DNA in patients with systemic lupus erythematosus. Their role in the diagnosis, the follow-up and the pathogenesis of the disease. Clin. Rheumatol. (Suppl) 9: 100-110.
12. EGNER, W. 2000. The use of laboratory tests in diagnosis of SLE. J. Clin. Pathol. 53: 424-432.
13. KOHDA, S. et al. 1989. Clinical significance of antibodies to histones in systemic lupus erythematosus. J. Rheumatol. 16: 24-28.
14. WOOSLEY, R.I. et al. 1987. The effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. N. Engl. J. Med. 298: 1157-1159.
15. HARDIN, J.A. 1986. The lupus autoantigens and the pathogenesis of systemic lupus erythematosus. Arthritis Rheum. 29: 457-460.
16. TAN, E.M. 1989. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv. Immunol. 44: 93-151.
17. ISENBERG, D.A. 1994. The origin, sequence structure, and consequences of developing anti-ds DNA antibodies. A human perspective. Arthritis Rheum. 37: 169-180.
18. BERDEN, J.H.M. et al. 2002. Lupus nephritis: a nucleosome waste disposal defect? J. Nephrol. 15: S1-S10.
19. CASCIOLA-ROSEN, L.A et al. 1994. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surfae structures on apoptotic keratinocytes. J. Exp. Med. 179: 1317-1330.
20. AMOURA, Z. et al. 1999. The key role of nucleosomes in lupus. Arthritis Rheum. 42: 833-843.
21. GHILLANI-DALBIN, P. et al. 2003. Testing for anti-nucleosome antibodies in daily practice: a monocentric evaluation in 1696 patients. Lupus 12: 833-837.
22. AMOURA, Z. et al. 2000. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases. Antinucleosome antibodies of the IgG 3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Arthritis Rheum. 43: 76-84.
23. SUENAGA, R. et al. 1998. Isolation of anti-nucleosome antibodies from the plasma of lupus nephritis patients. Clin. Rheumatol. 17: 189-194.
24. HMIDA, Y. et al. 2002. Failure to detect antinucleosome antibodies in scleroderma: comment on the article by Amoura et al. Arthritis Rheum. 46: 280-282.
25. BOUMPAS, D.T. et al. 1995. Systemic lupus erythematosus emerging concepts. Part I: renal, neuropsychiatric, cardiovascular, pulmonary and haematologic disease. Ann. Intern. Med. 122: 940-950.
26. RAHMAN, A. & F. HIEPE. 2002. Anti-DNA antibodies-overview of assays and clinical correlations. Lupus 11: 770-773.
27. CORTEŹ-HERNÁNDEZ, J. et al. 2004. Antihistone and anti-double-stranded deoxyribonucleic acid antibodies are associated with renal disease in systemic lupus erythematosus. J. Med. 116: 165-173.
28. MIN, D.J. et al. 2002. Significance in lupus patients lacking anti-double-stranded DNA antibody. Clin. Exp. Rheumatol. 20: 13-18.
29. VAN BRUGGEN, M.C. et al. 1997. Nucleosomes and histones are present in glomerular deposits in human lupus nephritis. Nephrol. Dial. Transplant. 12: 57-66.
30. WILLIAMS, R.C. JR. et al. 1999. Anti-DNAand anti-nucleosome antibody affinity - a mirror image of lupus nephritis? J. Rheumatol. 26: 331-346.